retatrutide phase 2 trial type 2 diabetes weight loss 2024 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Triple hormone receptor agonist retatrutide

But that timeframe comes with some significant, non-negotiable caveats

B12, Lipo B12, and Vitamin D a fast way to support your energy and wellness between visits

It works in a similar way to injectable GLP-1 receptor agonists like Wegovy and Mounjaro, but in a pill form that does not require refrigeration or needles

Our experience shows that labeling the vial with the date of reconstitution and the final concentration (e.g., "Recon 10/26 5mg/mL") is a foolproof way to prevent this

[11] People with type 2 diabetes on insulin or sulphonylureas require careful monitoring due to the risk of hypoglycaemia when combining these agents

As laboratories worldwide explore its potential applications, understanding the science behind this innovative peptide becomes crucial for researchers and peptide enthusiasts alike